ATC Group: A03FA01 Metoclopramide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03FA01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for functional gastrointestinal disorders
3
Propulsives
4
Propulsives
5
A03FA01
Metoclopramide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
30 mg
PAREN - Parenteral
30 mg
RECTAL - Rectal
30 mg

Active ingredients in A03FA01

Active Ingredient
Description

The action of metoclopramide is closely associated with parasympathetic nervous control of the upper gastro-intestinal tract where it has the effect of encouraging normal peristaltic action. This provides for a fundamental approach to the control of those conditions where disturbed gastrointestinal motility is a common underlying factor.

Medicines in this ATC group

Drug
Countries

South Africa

Ecuador Spain

Hong Kong

Austria

Estonia Lithuania

South Africa

South Africa

Ecuador

Cyprus Hong Kong

Ecuador

Hong Kong Tunisia

Estonia

South Africa

Cyprus Estonia Lithuania

Singapore

Estonia

Australia

South Africa

Hong Kong

Hong Kong

Australia Ireland New Zealand South Africa United Kingdom ...

New Zealand

South Africa

Hong Kong

Hong Kong

Hong Kong

New Zealand

Hong Kong

Austria Germany

Estonia South Africa

Hong Kong

Brazil

Brazil

Brazil Italy

Brazil

Tunisia

South Africa

Australia

Cyprus Estonia Finland France Hong Kong ...

Hong Kong

South Africa

Singapore

South Africa United States

Hong Kong

Hong Kong Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
CY
Summary of Product Characteristics (SPC)
CY
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Structured Product Labeling (SPL/PLR)
US